Clinical trial
Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors
NCT01858155 is registered in ClinicalTrials.gov with C17 Council as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors
- Lead sponsor
- C17 Council
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- December 31, 2017
- Enrollment
- 9 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed malignant solid tumor